Eph receptor tyrosine kinases and their ligands (ephrins) are key players during the development of the embryonic vasculature; however, their role and regulation in adult angiogenesis remain to be defined. Both receptors and ligands have been shown to be up-regulated in a variety of tumors. To address the hypothesis that hypoxia is an important regulator of Ephs/ephrins expression, we developed a mouse skin flap model of hypoxia. We demonstrate that our model truly represents segmental skin hypoxia by applying four independent methods: continuous measurement of partial cutaneous oxygen tension, monitoring of tissue lactate/pyruvate ratio, time course of hypoxia-inducible factor-1α (HIF-1α) induction, and localization of stabilized HIF-1α by immunofluorescence in the hypoxic skin flap. Our experiments indicate that hypoxia up-regulates not only HIF-1α and vascular endothelial growth factor (VEGF) expression, but also Ephs and ephrins of both A and B subclasses in the skin. In addition, we show that in Hep3B and PC-3 cells, the hypoxia-induced up-regulation of Ephs and ephrins is abrogated by small interfering RNA-mediated down-regulation of HIF-1α. These novel findings shed light on the role of this versatile receptor/ligand family in adult angiogenesis. Furthermore, our model offers considerable potential for analyzing distinct mechanisms of neovascularization in genetargeted mice.
receptor/ligand family is therefore that the interaction between receptor and ligand requires juxtacrine contact. Intriguingly, ligand-receptor contact can lead to bidirectional signaling in both receptor-and ligand-expressing cells. Eph receptors have emerged as essential regulators of angiogenesis in vivo, comparable in importance to vascular endothelial growth factor (VEGF) and angiopoietins. During the embryonic phase, Eph receptors regulate pivotal developmental changes, including cell migration, axonal guidance and angiogenesis (4) . In the adult, they have been shown to be up-regulated in some tumor tissues and presumably to be involved in pathogenic neovascularization. This is partly related to their interactions with focal adhesion molecules (5-7) and integrins (8, 9) . Furthermore, recent studies have provided evidence that antagonizing EphA2 or EphB2 either by a recombinant protein EphA2/Fc (10, 11) or by a specific antibody anti-EphB2, respectively (12) , could slow down both angiogenesis and tumor growth in various mouse models. However, the mechanisms linking cancer to this intriguing receptor-ligand family still remain to be elucidated.
Recently, local tissue hypoxia has been demonstrated to play a central role in angiogenesis. The cellular response to oxygen deprivation involves a series of metabolic and biosynthetic events associated with adaptation to a hypoxic environment. The effects of the hypoxia-induced gene products aim to counteract the detrimental effects of low oxygen, while angiogenic factors attract new vasculature to increase oxygenation. Therefore, we hypothesized that hypoxia might be an important mediator linking Ephs/ephrins expression to neovascularization.
A prerequisite for an ideal animal model to study the effects of hypoxia on angiogenic and repair processes is a direct and continuous monitoring of the degree of tissue hypoxia and an assessment of the resulting metabolic and histopathologic changes. We have previously shown that Ephs and ephrins are expressed in dermal endothelial cells and keratinocytes (13) . MartinyBaron and colleagues presented evidence for a role of EphBs and ephrinBs in tumor growth and angiogenesis in A475 melanoma xenografts (14) . The skin seems thus to be an ideal tool to study the regulation and angiogenic function of Ephs/ephrins. Therefore, we developed a mouse model to monitor in situ the degree of tissue hypoxia and to assess the histopathologic changes and the gene expression patterns of Ephs/ephrins under hypoxic conditions.
MATERIALS AND METHODS

Dorsal skin flap design and assessment of tissue hypoxia
Animal experiments were conducted according to NIH guidelines for the care and use of laboratory animals and with the approval of the local Animal Ethics Committee. Eight female Balb/C mice weighing 20-25 g were included in this study. The animals were anesthetized with a cocktail comprising medetomidine hydrochloride 0.25 mg/kg, climazolamum 2.5 mg/kg and fentanyl citrate 0.025 mg/kg given intraperitoneally (ip) and supplemented when necessary. After shaving and epilating the dorsal skin, an island skin flap of 40 × 30 mm was dissected free from the surrounding tissue using an operating microscope (Fig. 1A) (15) . The dorsal skin flap was pedicled on a branch of the deep circumflex iliac vessels on each side. The flap was designed in such a way that hypoxia occurred in the distant, cranially located areas without leading to subsequent necrosis, as confirmed by preliminary experiments. The flap was then stretched to its original size, and the probes inserted using an operating microscope with ×10 magnification. During surgery, 4 mg papaverine hydrochloride (Sigma, St. Louis, MO) dissolved in 1 ml 0.9% saline solution was administered drop-wise on the vascular pedicle to prevent vasospasm. Thereafter, the flap was sutured back to its origin (Fig. 1B) .
Partial tissue oxygen tension was assessed by Clark-type microprobes, consisting of polarographic electrodes and an oxygen-sensitive microcell (Revoxide CC1; GMS, KielMielkendorf, Germany). The probes were inserted into the subcutaneous tissue through a venous 22G catheter. Large arterioles or venules inside the sampling area were avoided when probes were assessed.
The interstitial concentrations of glucose, pyruvate, and lactate were measured by microdialysis, as described previously (16, 17) . The system included microprobes (CMA/20; CMA Microdialysis AB, Solna, Sweden) with a microcell perfused by a microinjection pump (CMA/100; CMA Microdialysis AB). The microcell consisting of a polyethersulfone membrane was continuously perfused with isotonic Ringer's solution. The outlet tube was connected to a refrigerated fraction collector (CMA/200 F; CMA Microdialysis AB). Dialysate samples were collected into microvials for laboratory analyses for 45 min each (CMA 600; CMA Microdialysis AB). Before each experiment, probes were equilibrated according to the guidelines of the supplier, and the recovery of particular substances was calculated. Glucose, lactate, and pyruvate concentrations were measured in the CMA 600 analyzer.
Probes were inserted into the healthy neck skin (control), the well-vascularized caudal intermediate part of the flap, and the hypoxic cranial part of the flap (Fig. 1A) . Partial tissue oxygen tension and interstitial metabolite concentrations were measured up to 8 h after induction of hypoxia. Body temperature was maintained at 30 ± 4°C using a heating pad and a cover. Tissue samples were taken from the flap and the normal skin for quantitative real-time PCR and immunoblotting analysis each hour. Afterward the animals were given 1.5 ml of 5% glucose ip, and a mixture of atipamezoli hydrochloridum 2.5 mg/kg, sarmazenilum 0.5 mg/kg and naloxoni hydrochloridum 1.2 mg/kg as antidote. The animals were kept under a warming lamp for 12 h. The animals monitored for any signs of pain and autocannibalism were killed either directly, or 1 to 2 days after surgery by an overdose of the anesthesia cocktail.
Isolation of total RNA and quantification of mRNA by real-time RT-PCR
Mouse skin, biopsy samples were powderized with a metal homogenizer and further disrupted by The FastPrep System (BIO 101 Systems, Basel, Switzerland) using Lysing matrix D tubes (BIO 101 Systems) containing Trizol reagent (Invitrogen AG, Basel, Switzerland). Total RNA isolated according to the manufacturer's standard method was digested with DNaseI (Sigma) to degrade genomic DNA. RNA pools were reverse-transcribed with Murine Leukemia Virus reverse transcriptase (MuLV) (Applied Biosystems, Foster City, CA) in GeneAmp PCR System 9700 (Applied Biosystems).
Quantitative real-time PCR was performed by using ABI Prism 7000 Sequence Detection System (Applied Biosystems). The Assays-on-Demand products purchased from Applied Biosystems, contained Taqman minor groove binder (MGB) probes (6-FAM dye-labeled) combined with the primers for the genes of interest: HIF-1α (Mm00468869_m1; Hs00153153_m1), VEGF (Mm00437304_m1; Hs00173626_m1), EphB4 (Mm00438750_m1; Hs00174752_m1), ephrinB2 (Mm00438670_m1; Hs00187950_m1), EphA2 (Mm00438726_m1;
Page 3 of 22 (page number not for citation purposes) 00171656_m1), and ephrinA1 (Mm00438660_m1; Hs00358886_m1). An Assay-on-Demand product for eukaryotic 18S rRNA (Hs99999901_s1) was used as endogenous control. The PCR was performed according to a previously described protocol (18) . For each individual gene, mRNA expression in each tissue sample was analyzed in triplicate in four animals. The data were analyzed with ABI Prism 7000 SDS Software Version 1.1 (Applied Biosystems), and normalized to the expression levels of eukaryotic 18S rRNA.
Immunoblot analysis
SDS-PAGE was performed with 40 or 60 μg of nuclear or cytoplasmic proteins isolated from mouse skin, according to protocols published previously (19, 20) . Proteins were transferred onto polyvinylidene fluoride membranes (PVDF; Millipore, Bedford, MA, USA) and detected using monoclonal HIF-1α antibody (Novus Biologicals, Littleton, CO) or monoclonal VEGF antibody or polyclonal rabbit antibodies against EphA2 or ephrinB2 (Santa Cruz Biotechnology, Santa Cruz, CA). Polyclonal rabbit EphB4 antibody was a kind gift from Prof. A. Ziemiecki (University of Bern, Switzerland) and ephrinA1 antibody was from Dr. D. P. Cerretti (Amgen, Seattle, WA). Equal loading and transfer were verified by incubating the membranes with monoclonal p53 antibody (Oncogene Research, Darmstadt, Germany) for nuclear proteins or with rabbit anti-β-actin (Santa Cruz Biotechnology) for cytoplasmic proteins. Protein expressions are given as a ratio to the loading control.
Histology, immunohistochemistry, and immunofluorescence analyses
Biopsies from hypoxic and normoxic parts of the skin were taken after 24-48 h and fixed in 5% formalin overnight, and embedded in paraffin. Five-μm sections were used for hematoxylin and eosin (HE) staining, while 0.5-μm sections were stained with monoclonal HIF-1α antibody (Novus Biologicals) for immunofluorescence analysis or with antibodies against Eph receptors and ligands of both A and B subclasses mentioned above. Bound antibody was visualized using FITC conjugated donkey anti-mouse antibody (Jackson Immunoresearch Laboratories, La Roche, Switzerland), Alexa Fluor 495 goat anti-rabbit IgG or Alexa Fluor 488 goat anti-mouse (Molecular Probes, Leiden, The Netherlands). Fluorescence was monitored with a Nikon Eclipse E600 microscopy (Nikon, Tokyo, Japan) connected to Nikon digital camera DXM1200. The pictures were processed with the Nikon AC-1 software version 2.11. VEGF, EphB4, ephrinB2, EphA2 and ephrinA1 proteins were detected by standard immunohistochemistry protocol. The monoclonal Ki-67 antibody was purchased from DakoCytomation (Copenhagen, Denmark). The Eph receptor/ephrin ligand expressions in the skin were semiquantitatively scored using Image J software (http://rsb.info.nih.gov/ij/). The analysis was performed from one section representative of 3 independent experiments.
Small interfering RNA (siRNA) experiments
Human hepatoma cells (Hep3B) and human prostate cells (PC-3) were cultured in RPMI 1640 medium (Invitrogen AG) and DMEM medium (Invitrogen AG), respectively, containing 10% fetal bovine serum (FBS) and antibiotics. The Hep3B and PC-3 cells were transiently transfected using the Silencer siRNA transfection II kit (Ambion, Austin, TX) containing siPORT neoFX, or siPORT Amine transfection reagent, respectively, according to the manufacturer's instructions. The transfection mixture was removed after incubation with cells for 24-28 h at +37°C. Then
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cells were further incubated under normal growth conditions for 24 h before the use for mRNA and protein determination. For the hypoxia exposure, the cells were treated with 200-μM cobalt chloride (CoCl 2 ) (Sigma) for 8 or 20 h before the experiments. Chemically synthesized siRNA oligonucleotides (Ambion) for HIF-1α (sense: GGGUAAAGAACAAAACACAtt, antisense: UGUGUUUUGUUCUUUACCCtt) and a nonsilencing control siRNA (provided with the transfection kit) were used for transfection at a final concentration of 30 nM.
Statistical analysis
The time-related differences between repeat measurements and the differences between the groups were assessed by the paired and unpaired ANOVA, respectively. The paired and unpaired ANOVA were followed by the Dunnett's and Tukey's post hoc test, respectively. A value of P< 0.05 was considered statistically significant.
RESULTS
The dorsal skin flap model of segmental hypoxia
The hypoxic part of the flap showed significantly lower mean levels (±SEM) of partial cutaneous oxygen tension (3.44±0.12 mmHg) compared with its intermediate part (17.3±0.31 mmHg) or the normal skin (27.3±0.22 mmHg) (n=8, P<0.05, Fig. 2A, top) . Every 30 min for a period of 8 h, microdialysis samples from all three parts of the skin were taken to determine the lactate/pyruvate ratio. The mean lactate/pyruvate ratio was significantly increased in the hypoxic part of the flap (80.4±2.14) when compared with the intermediate part (26.4±0.84) or the normal skin (18.6±0.68) (n=8, P<0.05, Fig. 2A, bottom) 
Time-course of HIF-1α expression and subsequent VEGF induction
The transcriptional activator hypoxia-inducible factor-1 (HIF-1) functions as a global regulator of oxygen homeostasis. This activator is a heterodimer consisting of constitutively expressed HIF-1β subunit and an O 2 -regulated HIF-1α subunit (21) . Under hypoxic conditions, stabilized HIF-1α induces the expression of genes involved in angiogenesis, erythropoiesis and glucose metabolism, such as VEGF, erythropoietin or glycolytic enzymes (22, 23) . Therefore, we assessed the expression of its oxygen-dependent α-subunit in the hypoxic flap compared with the normal skin. The mRNA levels of HIF-1α were enhanced after 4 h of hypoxic exposure (Fig. 2B,  top) , reached maximal levels after 6 h (6.4-fold compared with normal skin) and decreased back to normal after 8 h. The increase of HIF-1α protein expression reached its maximum after 24 h of exposure (6.9-fold) (Fig. 2B, bottom) .
These findings were strongly corroborated by immunofluorescence studies. After 24 h exposure to hypoxia, strong accumulation of HIF-1α occurred in endothelial and adjacent cells (Fig. 2Ca) , while no HIF-1α staining was observed in normal skin (Fig. 2Cb) .
The time-dependent expression of the VEGF, a well-established target gene for HIF-1 and a strong stimulator of angiogenesis, was up-regulated in a similar fashion. The highest VEGF mRNA levels were observed 6 h after hypoxia (8.5-fold compared with normal skin) (Fig. 3A,  top) , while VEGF protein reached its peak 24 h after hypoxia (4.3-fold) (Fig. 3A, bottom) , and were still high after 48 h (3.7-fold). These results were confirmed by immunohistochemistry analysis (Fig. 3B) .
Histological changes in the hypoxic skin flap
Inflammatory changes in response to hypoxia were demonstrated by the presence of fibrinogen in the epidermis, as well as lymphomonocytic infiltration of the subcutis after 48 h (Fig. 4Ab and Ac). Futhermore, the hypoxic skin sections clearly showed disruption of the affected vessel walls (Fig. 4Ad) . However, there were no signs of tissue necrosis, in contrast to conventional ischemic flap models.
In addition, using Ki-67 as a cell proliferation marker, we showed that the number of proliferating endothelial cells in dermal vessels increased significantly after 24 h of hypoxia (4.4-fold) compared with normal skin and increased even further 48 h after hypoxia (18-fold) (P<0.05, Fig. 4B ).
EphB4, ephrinB2, EphA2, and ephrinA1 are up-regulated in the hypoxic skin Having validated our model, we next looked at the temporal expression patterns of Eph receptors and ephrins in the hypoxic skin.
EphB4 mRNA expression was induced after 6 h and continued until 24 h after onset of hypoxia (Fig. 5A, top) , reaching maximal levels after 12 h (5.8-fold up-regulation compared with the normal skin). EphB4 protein was 10-fold up-regulated after 24 h of hypoxia (Fig. 5A, bottom) . The cognate ligand of EphB4, ephrinB2, was up-regulated in a more moderate fashion. Maximal up-regulation of ephrinB2 mRNA was observed after 24 h (4.2-fold) (Fig. 5B, top) , while upregulation of ephrinB2 protein was 3.1-fold after 6 h and persisted until 48 h (Fig. 5B, bottom) .
The induction of EphA2 mRNA was seen after 12 h and reached its maximum after 24 h (8-fold) (Fig. 6A, top) . At the protein level the up-regulation of EphA2 was 2.5-fold after 24 h of hypoxia (Fig. 6A, bottom) . EphrinA1 mRNA up-regulation was seen after 6 h and continued until 48 h after induction of hypoxia, reaching its peak after 24 h (5-fold) (Fig. 6B, top) . EphrinA1 protein was strongly up-regulated (19.8-fold) after 24 h of hypoxia (Fig. 6B, bottom) .
In agreement with the gene expression data, immunohistochemistry analysis confirmed that EphB4, ephrinB2, EphA2, and ephrinA1 were significantly up-regulated after 24 h of hypoxia exposure (Fig. 7) . After 48 h, the expressions were lower than at the 24 h-time point, but still higher than in the normal skin. The results of a semiquantitative scoring analysis are shown in Fig. 7B .
RNA interference for HIF-1α inhibits the hypoxia-dependent up-regulation of Eph receptors/ephrins expression
To directly demonstrate that the regulation of Eph receptors/ephrins expression by hypoxia is indeed mediated by HIF-1α, we performed chemical hypoxia experiments with cobalt chloride (CoCl 2 ) and knocked down specifically HIF-1α using RNA interference. Under normoxic conditions, transfection of Hep3B and PC-3 cells with siRNA against HIF-1α had no effect on basal mRNA expression of HIF-1α or VEGF compared with nontransfected cells (Fig. 8A, lanes 
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2 and 10). The HIF-1α mRNA was enhanced 7.6-fold and 6-fold in PC-3 and Hep3B cells, respectively, after 8 h of CoCl 2 treatment (Fig. 8A, lanes 3 and 11) . The VEGF mRNA was upregulated in a similar fashion after 20 h of chemical hypoxia in both cells types: PC-3 cells showed a 5.3-fold up-regulation, whereas in Hep3B cells the up-regulation was 7.4-fold (Fig. 8A,  lanes 4 and 12) . The CoCl 2 -induced up-regulation of both HIF-1α and VEGF was clearly abrogated by siRNA against HIF-1α (Fig. 8A, lanes 5, 6, 13, and 14) , while random siRNA had no effect (Fig. 8A, lanes 8 and 16) . The effect of HIF-1α knockdown on EphA2 and ephrinA1 was assessed in PC-3 cells, whereas for EphB4 and ephrinB2, we used Hep3B cells. The prominent reduction of relative mRNA levels of EphB4, ephrinB2, EphA2, and ephrinA1 caused by transfection with siRNA against HIF-1α is shown in Fig. 8B , C. The results on the mRNA level were clearly confirmed at the protein level by immunofluorescence experiments (Supplemental Figs. 2 and 3 ).
DISCUSSION
Angiogenesis, the formation of new blood vessels from pre-existing vasculature, is a multistep process, involving a diverse array of molecular signals. These include factors that stimulate endothelial cell proliferation, migration, and assembly, as well as recruitment of perivascular cells and extracellular matrix remodeling. Endothelial cell RTKs have been recognized as critical mediators of angiogenesis: these are the VEGF receptor, Tie and Eph RTKs. The function of both VEGF/VEGF receptor and angiopoietins/Tie-2 receptor families in vascular development and angiogenesis are well studied (3). The Eph RTK family, however, represents a newer class of RTKs, and its role in angiogenesis, especially in the adult organism, is beginning to emerge.
Eph receptors and ephrins have been shown to mediate important biological processes in the developing organism. In particular, reciprocal expression of Eph/ephrin molecules between endothelial and mesenchymal cells might be important for the differentiation of mesenchymal cells into perivascular cells, which is critical for the stability of mature vessels (24) . Less clear is the role of Eph receptors and ephrins in the adult organism. Up-regulation of EphA2 and EphB2 has been shown in a variety of tumors such as breast, skin, brain, and colorectal cancer (12, (25) (26) (27) . In transgenic mouse models of mammary carcinogenesis, EphA2 and EphB4 were detected in invasive primary tumors of mice expressing the H-Ras oncogene, but not in the welldifferentiated and nonmetastatic mammary tumors of c-Myc-expressing mice (28) . Despite a growing number of studies linking increased expression of Eph receptors to cancer, the underlying regulatory mechanisms still remain to be elucidated.
The relevance of hypoxia signaling for tumor angiogenesis has been demonstrated in experimental models of tumors lacking a functional HIF complex, which are less vascularized and grow significantly slower (29, 30) . In the present study, we thus addressed the hypothesis that the regulation of Eph/ephrin expression could be mediated by hypoxia. To this purpose, we first developed a model, which would allow us to study the biological effects of local hypoxia resulting from hypoperfusion. The mouse dorsal skin flap model presented here enabled us to quantify and monitor the degree of local tissue hypoxia by using four independent methods: continuous measurement of partial cutaneous oxygen tension, monitoring of tissue lactate/pyruvate ratio, time-course of HIF-1α induction, and immunofluorescence localization of stabilized HIF-1α in the hypoxic flap. Significantly reduced partial oxygen tension and increased lactate/pyruvate ratio were found in the cranial, collateralized part of the flap, thus suggesting severe hypoxia, a contention confirmed by the accumulation of stabilized HIF-1α, as demonstrated by immunofluorescence. Finally, histological examination ruled out ischemiarelated tissue necrosis, thus enabling a semiquantitative analysis of multiple genes in hypoxic tissue. To the best of our knowledge, this is the first time that a model of local tissue hypoxia was set up in such a precise and reproducible way.
Although HIF-1α expression has been reported to be regulated post-transcriptionally in cultured cells (31, 32) , in vivo regulation of HIF-1α appears to be more complex. Systemic and local factors such as regional changes in blood flow and differences in cellular oxygen consumption may affect the degree of cellular hypoxia and thus the response of individual cell types. In agreement with our results, significant induction of HIF-1α mRNA expression was observed only after 7.5 h of permanent focal ischemia in rat brain, with a significant increase up to 20 h (33).
As for HIF-1α protein expression, the induction of HIF protein has been shown to be an early event in the sequence of cellular changes after the interruption of blood flow. Consistent with our findings, it has been reported that the up-regulation of HIF-1α protein reached its maximum after 1 to 2 days in the hypoxic rat kidney (34) . Similar results were obtained for the rat brain, in which HIF-1α expression increased between 8 and 24 h after ischemia (35) . In contrast, levels of HIF-1α protein in the brain of mice exposed to 6% hypoxia were maximal after 5 h, but declined afterwards, reaching basal levels after 12 h (36). This difference in the time course of HIF-1α protein expression could be due either to tissue specific regulation or to differences in experimental design.
VEGF plays a critical role in neoangiogenesis and blood vessel permeability and has been shown to be up-regulated by HIF-1 (29, 30) . Through semi-quantitative analysis of both VEGF mRNA and protein expression, as well as its immunohistochemical localization in the mouse skin, our model allowed us a precise assessment of the kinetics of VEGF induction by local dermal hypoxia. Furthermore, we observed an increased number of dermal blood vessels expressing VEGF and Eph receptors/ephrins. VEGF is a strong inducer of endothelial cell proliferation, while Eph receptors play a pivotal role in their correct targeting. Our findings thus suggest that the VEGF/VEGF receptor and ephrins/Eph receptors families act synergistically in the mouse skin to induce angiogenesis in response to local hypoxia (Fig. 9 ).
In addition, to quantify cellular responses to hypoxia in the mouse skin, we used the immunohistochemical detection of Ki-67, a nuclear protein tightly associated with somatic cell division (37) . Since endothelial cell division is a prerequisite for neovascularization, our demonstration of marked Ki-67 staining of vascular endothelial cells after 24 to 48 h can be considered as an early indicator of new vessel formation in response to hypoxia.
In our analyses of dorsal skin, we now identified an increased number of blood vessels expressing Eph receptors and ephrins, indicating that hypoxia up-regulates Ephs/ephrins in the mouse skin. These findings suggest a potential role for Ephs/ephrins in tissue repair and wound healing, extending thus their function in adult angiogenesis beyond tumor neovascularization. Interestingly, the most prominent up-regulation was seen with EphB4 and ephrinA1 ligand, suggesting a complementary role of A and B subclasses of receptors and ligands in the hypoxia response. Since bidirectional signaling is a hallmark of Eph/ephrin interaction (4), our observation raises the possibility that this complementary pattern not only reflects a redundancy of signaling, but could also demarcate boundaries between different regions, an important issue deserving further consideration.
Finally, we used RNA interference to prove that HIF-1α, indeed, is mediating hypoxia-dependent up-regulation of Eph receptors/ephrins expression in cultured Hep3B and PC-3 cells. For this purpose, the cells were transfected with siRNA duplexes targeting HIF-1α before being subjected to chemical hypoxia by CoCl 2 treatment. CoCl 2 -induced hypoxia enhanced HIF-1α expression in nontransfected cells by real-time RT-PCR and by immunofluorescence, findings that were not seen in cells not exposed to CoCl 2 . However, when the cells were transfected with siRNA duplexes before hypoxia treatment, HIF-1α mRNA and protein induction were largely abrogated. In contrast, random siRNA duplexes did not inhibit HIF-1α expression in cells exposed to chemical hypoxia. Similar results were obtained for VEGF and Ephs/ephrins expressions on both mRNA and protein levels. In aggregate, these experiments definitely establish HIF-1α as a key regulator of Ephs/ephrins expression under hypoxic conditions.
In conclusion, we have validated a new in vivo model, allowing continuous and reliable, quantitative assessment of local, segmental tissue hypoxia in the mouse. The considerable potential utility of this versatile model is the in situ assessment of molecular, metabolic, and histological parameters relevant for the understanding of local tissue hypoperfusion causing a defined degree of hypoxia. As a proof of principle for the utility of this model, we demonstrated that hypoxia is a strong stimulator for the expression of Eph receptors and ephrins. These in vivo results were strongly corroborated by our RNA interference studies, where we demonstrated that HIF-1α siRNA treatment abrogates hypoxia-induced up-regulation of Eph receptors and ephrins of both subclasses. Although ephrinB2 has recently been shown to be induced by hypoxia in endothelial cells (38) , to the best of our knowledge, our study is the first to assess its relevancy in vivo, and to identify HIF-1α as an important regulatory factor. Our findings shed new light on the regulation of this intriguing receptor/ligand family and present evidence for the role of Ephs/ephrins in tissue repair and wound healing, extending thus their function in adult angiogenesis beyond tumor neovascularization. 
